• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Integrated Multidisciplinary Brain Metastasis Care Reduces Patient Visits and Shortens Time to Adjuvant Irradiation.多学科综合脑转移治疗可减少患者就诊次数并缩短辅助放疗时间。
JCO Oncol Pract. 2022 Nov;18(11):e1732-e1738. doi: 10.1200/OP.22.00258. Epub 2022 Aug 29.
2
Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.早期对切除的脑转移瘤瘤床进行伽玛刀立体定向放射外科治疗以改善局部控制。
J Neurosurg. 2014 Dec;121 Suppl:69-74. doi: 10.3171/2014.7.GKS141488.
3
Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial.完全切除的脑转移瘤术后立体定向放射外科治疗与观察的比较:一项单中心、随机、对照、3期试验。
Lancet Oncol. 2017 Aug;18(8):1040-1048. doi: 10.1016/S1470-2045(17)30414-X. Epub 2017 Jul 4.
4
Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.术后立体定向放射外科与全脑放疗治疗脑转移瘤切除术(NCCTG N107C/CEC·3):一项多中心、随机、对照、3期试验
Lancet Oncol. 2017 Aug;18(8):1049-1060. doi: 10.1016/S1470-2045(17)30441-2. Epub 2017 Jul 4.
5
Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy.立体定向放射外科加强治疗寡转移脑疾病的切除床:挑战辅助全脑放疗的传统
Neurosurg Focus. 2009 Dec;27(6):E7. doi: 10.3171/2009.9.FOCUS09191.
6
Intracranial control and radiographic changes with adjuvant radiation therapy for resected brain metastases: whole brain radiotherapy versus stereotactic radiosurgery alone.辅助性放射治疗对切除的脑转移瘤的颅内控制及影像学改变:全脑放疗与单纯立体定向放射外科治疗的比较
J Neurooncol. 2014 Dec;120(3):657-63. doi: 10.1007/s11060-014-1601-4. Epub 2014 Sep 5.
7
Postsurgical Cavity Evolution After Brain Metastasis Resection: How Soon Should Postoperative Radiosurgery Follow?脑转移瘤切除术后术腔演变:术后立体定向放射治疗应多快进行?
World Neurosurg. 2018 Feb;110:e310-e314. doi: 10.1016/j.wneu.2017.10.159. Epub 2017 Nov 6.
8
Resection followed by stereotactic radiosurgery to resection cavity for intracranial metastases.颅内转移瘤切除术后对切除腔进行立体定向放射外科治疗。
Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):486-91. doi: 10.1016/j.ijrobp.2008.04.070. Epub 2008 Oct 14.
9
Current status and recent advances in resection cavity irradiation of brain metastases.脑转移瘤切除腔照射的现状和最新进展。
Radiat Oncol. 2021 Apr 15;16(1):73. doi: 10.1186/s13014-021-01802-9.
10
Single-Fraction Stereotactic Radiosurgery (SRS) Alone Versus Surgical Resection and SRS for Large Brain Metastases: A Multi-institutional Analysis.单纯单次分割立体定向放射外科治疗(SRS)与手术切除联合SRS治疗大脑大转移瘤的多机构分析
Int J Radiat Oncol Biol Phys. 2017 Oct 1;99(2):459-467. doi: 10.1016/j.ijrobp.2017.04.006. Epub 2017 Apr 11.

引用本文的文献

1
Antibody drug conjugates in metastatic brain tumors: current landscape, therapeutic potential and challenges.转移性脑肿瘤中的抗体药物偶联物:现状、治疗潜力与挑战
J Neurooncol. 2025 Jun 5. doi: 10.1007/s11060-025-05083-0.
2
Optimizing post-acute care inpatient rehabilitation for patients with brain metastasis: A systematic review of functional outcomes.优化脑转移瘤患者急性后期住院康复治疗:功能结局的系统评价
Support Care Cancer. 2025 Apr 25;33(5):418. doi: 10.1007/s00520-025-09468-9.
3
Consortium for Intracranial Metastasis Academic Research (CIMARa): Global interdisciplinary collaborations to improve outcomes of patient with brain metastases.颅内转移学术研究联盟(CIMARa):全球跨学科合作以改善脑转移患者的治疗结果。
Neurooncol Adv. 2025 Mar 4;7(1):vdaf049. doi: 10.1093/noajnl/vdaf049. eCollection 2025 Jan-Dec.
4
Provider Volume Impacts Neurosurgical Procedure Selection in Older Patients With High-Grade Glioma.医疗服务提供者的手术量影响老年高级别胶质瘤患者的神经外科手术选择。
Cancer Med. 2025 Apr;14(8):e70866. doi: 10.1002/cam4.70866.
5
Survival Among Patients With ERBB2-Positive Metastatic Breast Cancer and Central Nervous System Disease.ERBB2阳性转移性乳腺癌合并中枢神经系统疾病患者的生存情况
JAMA Netw Open. 2025 Jan 2;8(1):e2457483. doi: 10.1001/jamanetworkopen.2024.57483.
6
Intracranial Outcomes of De Novo Brain Metastases Treated With Osimertinib Alone in Patients With Newly Diagnosed EGFR-Mutant NSCLC.在新诊断的表皮生长因子受体(EGFR)突变的非小细胞肺癌(NSCLC)患者中,单独使用奥希替尼治疗初发性脑转移的颅内结局
JTO Clin Res Rep. 2023 Nov 19;4(12):100607. doi: 10.1016/j.jtocrr.2023.100607. eCollection 2023 Dec.
7
Outcomes Following Early Postoperative Adjuvant Radiosurgery for Brain Metastases.脑转移瘤术后早期辅助放射外科治疗的结果。
JAMA Netw Open. 2023 Oct 2;6(10):e2340654. doi: 10.1001/jamanetworkopen.2023.40654.
8
National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities.美国国家癌症研究所关于塑造脑转移瘤研究格局的合作研讨会:挑战和建议的优先事项。
Lancet Oncol. 2023 Aug;24(8):e344-e354. doi: 10.1016/S1470-2045(23)00297-8.
9
Building Team Medicine in the Management of CNS Metastases.组建团队医学以管理中枢神经系统转移瘤
J Clin Med. 2023 Jun 7;12(12):3901. doi: 10.3390/jcm12123901.
10
Relevance of the Updated Recursive Partitioning Analysis (U-RPA) Classification in the Contemporary Care of Patients with Brain Metastases.更新后的递归划分分析(U-RPA)分类在脑转移瘤患者当代治疗中的相关性。
Cancers (Basel). 2023 Jun 20;15(12):3255. doi: 10.3390/cancers15123255.

本文引用的文献

1
Brain Metastasis-A Distinct Oncologic Disease Best Served by an Integrated Multidisciplinary Team Approach.脑转移瘤——一种独特的肿瘤性疾病,最佳治疗方式是采用多学科综合治疗团队方法。
JAMA Oncol. 2022 Sep 1;8(9):1252-1254. doi: 10.1001/jamaoncol.2022.1928.
2
Durable 5-year local control for resected brain metastases with early adjuvant SRS: the effect of timing on intended-field control.早期辅助立体定向放射治疗(SRS)对切除的脑转移瘤的5年持久局部控制:时机对靶区控制的影响
Neurooncol Pract. 2021 Jan 21;8(3):278-289. doi: 10.1093/nop/npab005. eCollection 2021 Jun.
3
Timing of Adjuvant Fractionated Stereotactic Radiosurgery Affects Local Control of Resected Brain Metastases.辅助分次立体定向放射外科治疗时间影响切除脑转移瘤的局部控制。
Pract Radiat Oncol. 2021 May-Jun;11(3):e267-e275. doi: 10.1016/j.prro.2021.01.011. Epub 2021 Feb 10.
4
Mortality due to cancer treatment delay: systematic review and meta-analysis.癌症治疗延迟导致的死亡率:系统评价与荟萃分析
BMJ. 2020 Nov 4;371:m4087. doi: 10.1136/bmj.m4087.
5
Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient.脑转移瘤患者的生存:诊断特异性分级预后评估更新的总结报告和资格系数的定义。
J Clin Oncol. 2020 Nov 10;38(32):3773-3784. doi: 10.1200/JCO.20.01255. Epub 2020 Sep 15.
6
Survival Outcomes Among Lung Cancer Patients Treated Using a Multidisciplinary Team Approach.采用多学科团队方法治疗的肺癌患者的生存结果。
Clin Lung Cancer. 2018 Jul;19(4):346-351. doi: 10.1016/j.cllc.2018.01.006. Epub 2018 Feb 1.
7
Consensus Contouring Guidelines for Postoperative Completely Resected Cavity Stereotactic Radiosurgery for Brain Metastases.脑转移术后完全切除空腔立体定向放射外科的共识勾画指南。
Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):436-442. doi: 10.1016/j.ijrobp.2017.09.047. Epub 2017 Oct 4.
8
Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial.完全切除的脑转移瘤术后立体定向放射外科治疗与观察的比较:一项单中心、随机、对照、3期试验。
Lancet Oncol. 2017 Aug;18(8):1040-1048. doi: 10.1016/S1470-2045(17)30414-X. Epub 2017 Jul 4.
9
SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process.SQUIRE 2.0(卓越质量改进报告标准):通过详细的共识过程制定的修订版出版指南。
BMJ Qual Saf. 2016 Dec;25(12):986-992. doi: 10.1136/bmjqs-2015-004411. Epub 2015 Sep 14.
10
Adjuvant radiation for soft tissue sarcomas.软组织肉瘤的辅助放疗
Am Soc Clin Oncol Educ Book. 2015:e634-42. doi: 10.14694/EdBook_AM.2015.35.e634.

多学科综合脑转移治疗可减少患者就诊次数并缩短辅助放疗时间。

Integrated Multidisciplinary Brain Metastasis Care Reduces Patient Visits and Shortens Time to Adjuvant Irradiation.

机构信息

Department of Neurosurgery and Brain Metastasis Center, Memorial Sloan Kettering Cancer Center, New York, NY.

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.

出版信息

JCO Oncol Pract. 2022 Nov;18(11):e1732-e1738. doi: 10.1200/OP.22.00258. Epub 2022 Aug 29.

DOI:10.1200/OP.22.00258
PMID:36037413
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10166425/
Abstract

PURPOSE

Timely surgical cavity stereotactic radiosurgery (SRS) is an important adjuvant to brain metastasis resection, with earlier treatment associated with less frequent recurrence. The logistical complexity of treatment organization, however, has resulted in suboptimal start times postsurgically. We implemented a process improvement approach to reduce the time from surgery to adjuvant irradiation of resected brain metastases.

METHODS

A multidisciplinary working group used process mapping to identify opportunities to reduce visits and shorten treatment times. The care delivery process was modified to streamline perioperative SRS preparation with (1) early patient identification, (2) preoperative intrateam communication, and (3) consolidation of required steps. Plan-Do-Study-Act cycles were used for process improvement. The surgery-to-SRS initiation time interval was the primary outcome. Secondary outcomes included the number of associated patient encounters.

RESULTS

After implementation, the median (interquartile range) interval from surgery to SRS was reduced 48% from 27 (21-34) to 14 days (13-17; < .001). The rate of surgical cavity SRS within 30 days increased from 64% (n = 63 of 98) to 97% (n = 60 of 62; < .001). The median (interquartile range) number of CNS-associated encounters between resection and SRS decreased from 5 (4-6) to 4 (3-5; < .001). The proportion of patients who had > 1 magnetic resonance imaging/computed tomography between surgery and SRS decreased from 45% (44 of 98) to 13% (8 of 62; < .001). The time from surgery to systemic therapy resumption/initiation among patients treated within 90 days postoperatively decreased from 35 (24-48) to 32 days (23-40; = .074). There were no wound complications in either group.

CONCLUSION

Adjuvant SRS latency and treatment-associated encounters were significantly reduced after care-coordination implementation. This approach reduces patient and health care system burden and can be applied to other scenarios where early postoperative SRS administration is critical.

摘要

目的

及时进行手术腔立体定向放射外科(SRS)是脑转移瘤切除的重要辅助手段,治疗时间越早,复发频率越低。然而,由于治疗组织的后勤复杂性,导致手术后开始治疗的时间不理想。我们采用了一种改进流程的方法,以减少脑转移瘤切除术后辅助放疗的时间。

方法

一个多学科工作组使用流程映射来确定减少就诊次数和缩短治疗时间的机会。通过(1)早期患者识别、(2)术前团队内沟通和(3)所需步骤的整合,对护理提供流程进行了修改,以简化围手术期 SRS 准备工作。使用计划-执行-研究-行动循环进行流程改进。手术至 SRS 启动时间间隔是主要结局。次要结局包括相关患者就诊次数。

结果

实施后,手术至 SRS 的中位数(四分位距)间隔从 27 天(21-34 天)缩短至 14 天(13-17 天;<0.001)。30 天内进行手术腔 SRS 的比例从 64%(98 例中的 63 例)增加到 97%(62 例中的 60 例;<0.001)。切除和 SRS 之间的中枢神经系统相关就诊次数中位数(四分位距)从 5 次(4-6 次)减少至 4 次(3-5 次;<0.001)。手术和 SRS 之间进行>1 次磁共振成像/计算机断层扫描的患者比例从 45%(98 例中的 44 例)降至 13%(62 例中的 8 例;<0.001)。在 90 天内接受治疗的患者中,从手术到恢复/开始全身治疗的时间从 35 天(24-48 天)减少至 32 天(23-40 天;=0.074)。两组均无伤口并发症。

结论

实施护理协调后,辅助 SRS 潜伏期和治疗相关就诊次数显著减少。这种方法减轻了患者和医疗保健系统的负担,可应用于其他需要尽早进行术后 SRS 治疗的情况。